Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Thyrocare Technologies Ltd ( (IN:THYROCARE) ) has shared an announcement.
Thyrocare Technologies Limited has announced a postal ballot to seek shareholder approval for the appointment of Mr. Alok Kumar Jagnani as a Non-Executive & Non-Independent Director. The remote e-voting for this resolution will take place from August 28 to September 26, 2025, with results expected by September 29, 2025. This move is part of the company’s ongoing governance and management efforts, potentially impacting its strategic direction and stakeholder engagement.
More about Thyrocare Technologies Ltd
Thyrocare Technologies Limited operates in the healthcare industry, primarily focusing on diagnostic and preventive healthcare services. The company is known for its diagnostic laboratory services, offering a wide range of tests and health check-up packages, and is a significant player in the Indian diagnostic sector.
Average Trading Volume: 9,382
Technical Sentiment Signal: Buy
Current Market Cap: 66.9B INR
For detailed information about THYROCARE stock, go to TipRanks’ Stock Analysis page.